Issued Patents All Time
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12351640 | Chimeric antigen receptor and CAR-T cells that bind BCMA | Armin Rehm, Uta Höpken, Julia Bluhm, Wolfgang Uckert, Elisa Kieback | 2025-07-08 |
| 12156959 | Extracorporeal devices for methods for treating diseases associated with anti-neutrophil cytoplasmic antibodies | — | 2024-12-03 |
| 12048718 | Chimeric antigen receptor and CAR-T cells that bind BCMA | Armin Rehm, Uta Höpken, Julia Bluhm, Wolfgang Uckert, Elisa Kieback | 2024-07-30 |
| 11820829 | Humanized antibodies against CD269 (BCMA) | Felix Oden, Oliver Daumke | 2023-11-21 |
| 11667722 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Martin Lipp, Felix Oden, Uta Höpken, Gerd Muller, Oliver Daumke +1 more | 2023-06-06 |
| 10851172 | Humanized antibodies against CD269 (BCMA) | Felix Oden, Oliver Daumke | 2020-12-01 |
| 10745486 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Martin Lipp, Felix Oden, Uta Höpken, Gerd Muller, Oliver Daumke +1 more | 2020-08-18 |
| 10189906 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Martin Lipp, Felix Oden, Uta Höpken, Gerd Muller, Oliver Daumke +1 more | 2019-01-29 |
| 10144782 | Humanized antibodies against CD269 (BCMA) | Felix Oden, Oliver Daumke | 2018-12-04 |